GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » NorthStar Healthcare Income Inc (OTCPK:NHHS) » Definitions » Sloan Ratio %

NorthStar Healthcareome (NorthStar Healthcareome) Sloan Ratio % : -15.62% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is NorthStar Healthcareome Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

NorthStar Healthcareome's Sloan Ratio for the quarter that ended in Mar. 2024 was -15.62%.

As of Mar. 2024, NorthStar Healthcareome has a Sloan Ratio of -15.62%, indicating there is a warning stage of accrual build up.


NorthStar Healthcareome Sloan Ratio % Historical Data

The historical data trend for NorthStar Healthcareome's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NorthStar Healthcareome Sloan Ratio % Chart

NorthStar Healthcareome Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.58 -14.81 -44.61 -6.26 -14.54

NorthStar Healthcareome Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.59 -12.39 -9.94 -14.54 -15.62

Competitive Comparison of NorthStar Healthcareome's Sloan Ratio %

For the REIT - Healthcare Facilities subindustry, NorthStar Healthcareome's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NorthStar Healthcareome's Sloan Ratio % Distribution in the REITs Industry

For the REITs industry and Real Estate sector, NorthStar Healthcareome's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where NorthStar Healthcareome's Sloan Ratio % falls into.



NorthStar Healthcareome Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

NorthStar Healthcareome's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-156.885-19.062
--21.884)/1059.419
=-14.54%

NorthStar Healthcareome's Sloan Ratio for the quarter that ended in Mar. 2024 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Mar. 2024 )
=(-150.891-23.525
--12.419)/1037.131
=-15.62%

NorthStar Healthcareome's Net Income for the trailing twelve months (TTM) ended in Mar. 2024 was -57.781 (Jun. 2023 ) + -11.218 (Sep. 2023 ) + -73.96 (Dec. 2023 ) + -7.932 (Mar. 2024 ) = $-150.9 Mil.
NorthStar Healthcareome's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2024 was 14.795 (Jun. 2023 ) + 1.807 (Sep. 2023 ) + 5.996 (Dec. 2023 ) + 0.927 (Mar. 2024 ) = $23.5 Mil.
NorthStar Healthcareome's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2024 was 3.858 (Jun. 2023 ) + -17.335 (Sep. 2023 ) + -7.589 (Dec. 2023 ) + 8.647 (Mar. 2024 ) = $-12.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NorthStar Healthcareome  (OTCPK:NHHS) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Mar. 2024, NorthStar Healthcareome has a Sloan Ratio of -15.62%, indicating there is a warning stage of accrual build up.


NorthStar Healthcareome Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of NorthStar Healthcareome's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


NorthStar Healthcareome (NorthStar Healthcareome) Business Description

Traded in Other Exchanges
N/A
Address
16 East 34th Street, 18th Floor, New York, NY, USA, 10016
NorthStar Healthcare Income Inc is a real estate investment trust. The trust is formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity seniors housing sector, such as assisted living, memory care, skilled nursing and independent living facilities and continuing care retirement communities. It also invests in other healthcare property types, including medical office buildings, hospitals, rehabilitation facilities and ancillary healthcare services businesses. The trust operates in five segments namely Direct Investments - Net Lease; Direct Investments - Operating; Unconsolidated Investments; Debt and Securities Investments; and Corporate.
Executives
Ann Harrington officer: General Counsel and Secretary C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Kendall K Young officer: CEO and President 3760 KILROY AIRPORT WAY, SUITE 300, LONG BEACH CA 90806
Nicholas Balzo officer: Chief Financial Officer 201 COMMONS PARK S, UNIT 502, STAMFORD CT 06902
Paul Varisano officer: Chief Financial Officer 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Neale Redington officer: Chief Financial Officer C/O COLONY NORTHSTAR, INC., 515 S. FLOWER ST., 44TH FLOOR, LOS ANGELES CA 90071
Jonathan A. Carnella director C/O NORTHSTAR HEALTHCARE INCOME, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Richard S. Welch director, officer: Chairman C/O COLONY NORTHSTAR, INC., 515 S. FLOWER STREET, LOS ANGELES CA 90071
Smith Jack Fleming Jr. director C/O NORTHSTAR REALTY FINANCE CORP., 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022
Gregory A Samay director C/O NORTHSTAR HEALTHCARE INCOME INC, 399 PARK AVE 18TH FLOOR, NEW YORK NY 10022
Thomas Andrew Smith director 111 WESTWOOD PLACE, SUITE 400, BRENTWOOD TN 37027
Justin T Chang director, officer: Chairman 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Daniel Joseph Altobello director 6550 ROCK SPRING DR, SUITE 550, BETHESDA MD 20817
Robert C Gatenio director, officer: Vice Chairman C/O COLONY NORTHSTAR, INC., 590 MADISON AVENUE, 34TH FLOOR, NEW YORK NY 10022
Frank V Saracino officer: CFO and Treasurer 399 PARK AVENUE, 18TH FLOOR, NEW YORK NY 10022
Ronald J Jeanneault officer: CEO and President C/O NORTHSTAR HEALTHCARE INCOME, INC., 399 PARK AVENUE, 18TH FL, NEW YORK NY 10022

NorthStar Healthcareome (NorthStar Healthcareome) Headlines

No Headlines